In vitro drug release study from hydroxyapatite-alumina composites
- 46 Downloads
Modern technologies require new materials with an increasingly varied set of properties. In this context, biomaterials such as synthetic hydroxyapatite have become of great interest for research and development in the field of materials science and engineering. In spite of its biocompatibility, hydroxyapatite suffers from low mechanical strength. Aiming to improve the mechanical properties of hydroxyapatite without affecting its biocompatibility, the formation of hydroxyapatite composites with alumina (Al2O3) as a reinforcement has been studied. In this work, hydroxyapatite was synthesized via a sol–gel method. Hydroxyapatite/alumina composites (HAp/Al2O3) were prepared in different proportions to determine the best combination to be used as a controlled release system of ampicillin. The samples obtained were characterized by X-ray diffraction and scanning electron microscopy. Mechanical behavior was evaluated by diametrical compression. After characterization of the composites, the sample with the highest mechanical resistance was chosen for the incorporation and release of ampicillin. The study showed very different release profiles, indicating that the release devices prepared may be useful in clinical applications that require varying times for treatment.
Hydroxyapatite successfully synthesized by the sol–gel method.
Formation of hydroxyapatite composites with alumina as a reinforcement has been studied.
Addition of alumina increased mechanical strength of the hydroxyapatite.
A composite with the highest mechanical resistance was chosen for release of ampicillin.
Release study revealed great potential of the composites for use in ampicillin delivery systems.
KeywordsHydroxyapatite Sol–gel Alumina Composites Drug release.
We are thankful to Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico (FUNCAP, Brazil) for their financial support.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- 1.Coelho J, Ferreira P, Alves P, Cordeiro R, Fonseca A, Góis J, et al. (2010) Drug delivery systems: advanced technologies potentially applicable in personalized treatments 1:164–209Google Scholar
- 3.Mitra S, Maitra A (2009) Inorganic Nanoparticles for Therapeutics, Drug and Gene Delivery. C.E.N.T.E.R.A., in book: Advances in Nanotechnology and Applications (vol. 1)Google Scholar
- 21.Korsmeyer R, Peppas N (1983) Macromolecular and modeling aspects of swelling-controlled systems. Control Release Deliv Syst 1983:77–90Google Scholar
- 22.Wang S Ordered mesoporous materials for drug delivery (2009) 117:1–9Google Scholar
- 25.Santos MH, Oliveira Md, LPdF Souza, Mansur HS, Vasconcelos WL (2004) Synthesis control and characterization of hydroxyapatite prepared by wet precipitation process. Mater Res 7:625–630Google Scholar
- 28.Evis Z, Doremus RH (2007) A study of phase stability and mechanical properties of hydroxylapatite–nanosize α-alumina composites 27:421–425Google Scholar
- 30.Tampieri A, Celotti G, Sprio S, Mingazzini C (2000) Characteristics of synthetic hydroxyapatites and attempts to improve their thermal stability 54–61Google Scholar
- 33.Bartonickova E, Vojtisek J, Tkacz J, Pořízka J, Masilko J, Moncekova M, et al (2017) Porous HA/Alumina composites intended for bone-tissue engineering 51:631–636Google Scholar
- 34.Hannora A (2014) Preparation and characterization of hydroxyapatite/alumina nanocomposites by high-energy vibratory ball milling 293–307Google Scholar
- 35.Shoaib MH, Tazeen J, Merchant HA, Yousuf RI (2006) Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci 19:119–124Google Scholar
- 39.Peppas NA (1985) Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60:110–111Google Scholar